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Introduction
Infective endocarditis (IE) is a disease that can cause serious com-
plications, and the risk of IE is higher in patients with underlying 
heart disease.1) Over the past several decades, IE was commonly 
Original Article
http://dx.doi.org/10.4070/kcj.2014.44.1.37
Print ISSN 1738-5520 • On-line ISSN 1738-5555
Changes in Patient Characteristics of Infective Endocarditis with  
Congenital Heart Disease: 25 Years Experience in a Single Institution
Jae Eun Baek, MD1, Su Jin Park, MD2, Saet Byul Woo, MD1,  
Jae Young Choi, MD1, Jo Won Jung, MD1, and Nam Kyun Kim, MD1
1Division of Pediatric Cardiology, Congenital Heart Disease Center, Severance Cardiovascular Hospital, Department of Pediatrics, Yonsei University College of Medicine, Seoul, 
2Department of Pediatric Cardiology, Sejong General Hospital, Bucheon, Korea
Background and Objectives: The profile of infective endocarditis (IE) has changed and is now showing an increasing prevalence of IE 
among congenital heart disease (CHD) patients. We studied the change of clinical profiles of IE over the past 25 years in patients with CHD 
at a single institution.
Subjects and Methods: We reviewed medical records retrospectively for 325 patients diagnosed with IE between January 1, 1987, and 
March 31, 2012. We analyzed and compared the differences in patient characteristics and outcomes between 1987-2000 (group A) and 
2001-2012 (group B).
Results: Over the 25-year period, 93 cases of IE in CHD patients were diagnosed (59 cases in group A and 34 cases in group B). Ventricular 
septal defect was the most common underlying cardiac disease observed during the entire period. The most common causative pathogen 
was Streptococcus in both groups. Group A contained 16 cases (27.1%) that had undergone cardiac surgery, whereas this number was 19 
(55.8%) in group B. The number of patients who had undergone palliative care or surgery using prosthetic materials was higher among group 
B patients (p<0.001). Surgical procedures due to uncontrolled infection were performed in three cases in group A and 10 cases in group B. 
Conclusion: Infective endocarditis and CHD show a close correlation, and the profile of IE patients can change in line with an increase in 
the survival rate of patients with complex CHD and the improvement of surgical techniques. Ongoing reassessment and the systematic 
management of these patients is crucial in the prevention and treatment of IE. (Korean Circ J 2014;44:37-41)
KEY WORDS: Infective endocarditis; Heart disease, congenital.
Received: October 5, 2013
Revision Received: November 5, 2013
Accepted: December 20, 2013
Correspondence: Nam Kyun Kim, MD, Division of Pediatric Cardiology, 
Congenital Heart Disease Center, Severance Cardiovascular Hospital, De-
partment of Pediatrics, Yonsei University College of Medicine, 50 Yonsei-
ro, Seodaemun-gu, Seoul 120-752, Korea
Tel: 82-2-2227-4565, Fax: 82-2-312-9538
E-mail: pednk@yuhs.ac
• The authors have no financial conflicts of interest.
This is an Open Access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work 
is properly cited.
associated with rheumatic heart disease and degenerative valvular 
heart disease. However, the profile of IE has since changed, with an 
increasing prevalence of IE among congenital heart disease (CHD) 
patients.2-4)
Reports on the clinical features of CHD with IE in different coun-
tries5)6) indicate that the occurrence of IE has different features ac-
cording to medical status, culture, and the region involved.7-9)
In Korea, there has been an increased survival rate of patients with 
CHD, but little is known about the occurrence of IE in these patients. 
Therefore, we reviewed cases of IE over the past 25 years at a single 
institution, and studied the change in theclinical profiles of IE in 
patients with CHD. 
Subjects and Methods
Study patients
We searched the Severance Cardiovascular Hospital database for 
CHD patients diagnosed with IE between January 1, 1987, and March 
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31, 2012. Modified Duke criteria10) were used for the diagnosis of IE, 
and the diagnosis of IE was made when the patients could be clas-
sified as suffering from definite endocarditis.
Data were collected from a retrospective review of patients’ re-
cords, which included patient demographics, history of CHD, caus-
ative organism, clinical course, complications, morbidity, and mor-
tality. We divided the patient data into two periods; group A of 
previously treated patients, hospitalized between 1987 and 2000; 
group B of more recently treated patients, hospitalized between 
2001 and 2012. We analyzed and compared the differences in pa-
tient characteristics and outcomes between the two groups.
Statistical analyses
Datawere analyzed using Statistical Package for the Social Sci-
ences (SPSS) 20 for Windows (SPSS Inc., Chicago, IL, USA). Means 
were analyzed using the Student t-test. For categorical data analy-
sis we used the chi-square test. A p of less than 0.05 was considered 
statistically significant.
Results
Demographic characteristics
During the 25-year period, 325 cases in 309 patients with IE were 
treated at our hospital. Of these, 93 cases (28.6%) across 87 pa-
tients, composed of 59 cases in group A (56 patients) and 34 cases 
in group B (31 patients), were diagnosed as having an underlying 
CHD. Five patients were patients with recurring symptoms; three 
patients in group A (56 patients) and two patients in group B (31 
patients). Only one patient had recurring symptoms three times, in 
group B.
The mean age ofthe patients was 17.9±14.7 years of age in group 
A and 24.4±18.6 years of age in group B; the difference was not sta-
tistically significant. There were no statistically significant differences 
between the groups in age: five cases (8.5%) in group A were young-
er than 1 year compared to two cases (5.9%) in group B. Twenty 
eight cases (47.4%) in group A were older than 18 years compared to 
18 cases (52.9%) in group B, and 26 cases (44.1%) in group A were 
between 1 and 18 years, compared to 14 cases (41.2%) in group B. 
However, the prevalence of cyanotic CHD {Tetralogy of Fallot (TOF), 
pulmonary atresia with ventricular septal defect (VSD), Ebstein’s 
anomaly, double-outlet right ventricle, and transposition of the 
great arteries} was significantly higher in group B than group A 
(p=0.001) (Table 1).
Associated heart disease
The most commonly associated heart disease was VSD in 39 cas-
es (41.9%) followed by TOF, at 12 cases (12.9%), and patent ductus 
arteriosus at 10 cases (10.7%). Non-cyanotic heart diseases such 
as VSD were the main cardiac conditions in group A, whereas cya-
notic heart diseases, such as TOF and pulmonary atresia with VSD, 
composed the main cardiac conditions in group B (Table 2).
We compared the incidence of IE in patients with or without prior 
cardiac surgery for underlying CHD. Of the total cases with CHD (n= 
93), we found 58 cases (62.3%) that had not, any cardiac surgery, 
and 35 cases (37.6%) that had undergone corrective or palliative 
Table 1. Baseline demographic characteristics of the two study groups (n=93)
Items Group A (n=59) Group B (n=34) p
Sex (n, male : female) 25 : 34 13 : 21 0.934
Age (years±SD) 17.9±14.7 24.4±18.6 0.072
Age <1 year of age (n, %) 5 (8.5) 2 (5.9) 0.834
1 year≤age≤18 years of age (n, %) 26 (44.1) 14 (41.2) 0.687
Age >18 years of age (n, %) 28 (47.4) 18 (52.9) 0.761
Cyanotic CHD (n, %) 10 (16.9) 17 (50) 0.001
Group A:  IE cases with CHD between 1987-2000, Group B: IE cases with CHD between 2001-2012. SD: standard deviation, IE: infective endocarditis, CHD: 
congenital heart disease
Table 2. Underlying congenital heart disease
Diagnosis (%) Group A (n=59) Group B (n=34) p
VSD 27 (45.7) 12 (35.3) 0.487
ASD 8 (13.5) 1 (2.9) 0.105
ECD 4 (6.7) 1 (2.9) 0.679
PDA 7 (11.9) 3 (8.8) 0.693
TOF 4 (6.8) 8 (23.5) 0.087
PA with VSD 0 (0) 6 (17.6) 0.002
DORV 5 (8.5) 2 (5.9) 0.684
PAPVR 2 (3.4) 0 (0) 0.454
Bicuspid AV 1 (1.7) 0 (0) 0.454
Ebstein’s anomaly 1 (1.7) 0 (0) 0.454
TGA 0 (0) 1 (2.9) 0.176
Group A: IE cases with CHD between 1987-2000, Group B: IE cases with 
CHD between 2001-2012. VSD: ventricular septal defect, ASD: atrial septal 
defect, ECD: endocardial cushion defect, PDA: patent ductus arteriosus, 
TOF: tetralogy of fallot, PA: pulmonary atresia, DORV: double-outlet right 
ventricle, PAPVR: partial anomalous pulmonary venous return, AV: aortic 
valve, TGA: complete transposition of the great arteries, IE: infective endo-
carditis, CHD: congenital heart disease
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cardiac surgery upon the diagnosis of IE. Group A (n=59) included 
16 cases (27.1%) that had undergone cardiac surgery, whereas this 
number was 19 (55.8%) in group B (n=34); this difference was sta-
tistically significant (p=0.004). Those patients who underwent cor-
rective surgery consisted of 15 cases in group A, but only eight cases 
in group B. However, patients who had undergone palliative care or 
surgery using prosthetic materials increased in group B to 11 cases 
compared to only one case in group A, which was statistically signif-
icant (p<0.001) (Table 3).
Causative microorganism
The most commonly identified causative microorganism in both 
groups was Streptococcus, with Staphylococcus aureus identified 
in one case in group A and five cases in group B. There were unique 
bacteria identified in group A, including Acinetobacter anitratus, 
Citrobactoer freundi, and Serratia marocescens. Candida albicans 
was also identified in three cases in group A. Thirty-five cases (37.6%) 
did not have an identified microorganism observed in blood cultures, 
and there was no statistical significance between the two groups 
(group A, 26 cases; group B, 9 cases; p=0.113) (Table 4). 
Treatment 
All patients who were diagnosed as having IE, were hospitalized 
and treated with an intravenous injection of antibiotics. The mean 
hospital stay was 48 days; 44 days in group A and 50 days in group 
B. Of these patients, 13 cases underwent early surgical procedures 
due to uncontrolled infections after the intravenous injection of 
antibiotics and increased complications, such as heart failure. Sur-
gical procedures were performed in three cases in group A (two cas-
es were for a removal of vegetation, and one case was valvuloplasty 
Table 3. Proportion of infective endocarditis according to prior cardiac surgery
History of operation Group A (n=59) Group B (n=34) p
Patients without prior cardiac surgery (%) 43 (72.9) 15 (44.1) 0.033
Patients with prior cardiac surgery (%) 16 (27.1) 19 (55.9) 0.004
Corrective surgery 15 (25.4) 8 (23.5) 0.801
Palliative surgery or prosthetic material 1 (1.7) 11 (32.4) <0.001
Group A: IE cases with CHD between 1987-2000, Group B: IE cases with CHD between 2001-2012. IE: infective endocarditis, CHD: congenital heart disease
Table 4. Causative microorganism
Microorganism Group A (n=59) Group B (n=34) p
Number of cases documented by blood culture (n, %) 33 (55.9) 25 (73.5) 0.113
Gram (+) organism
Staphylococci
Staphylococcus aureus
Methicillin-sensitive 2 2 0.568
Methicillin-resistant 2 3 0.263
Staphylococcuscoagulase negative
Staphylococcus epidermidis 1 2 0.271
Streptococci
Viridans streptococcus 15 13 0.195
Others 4 1 0.429
Enterococcus
Enterococcus faecalis 1 1 0.690
Gram (-) organism
Acinetobacter anitratus 2 0 0.278
Citrobactoer freundi 2 0 0.278
Serratia marocescens 1 0 0.445
Pseudomonas aeruginosa 0 3 0.020
Fungi
Candida albicans 3 0 0.181
Group A: IE cases with CHD between 1987-2000, Group B: IE cases with CHD between 2001-2012. IE: infective endocarditis, CHD: congenital heart disease
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with vegetation removal), and 10 cases in group B (nine cases re-
quired valvuloplasty, and one case had vegetation removal only).
Progress
The most common complication was heart failure associated with 
valvular dysfunction in 29 cases (group A, 14 cases; group B, 15 cas-
es), followed by eight cases of pulmonary embolism (group A, four 
cases; group B, four cases), and one case of brain artery infarction 
in group B. There was no surgical mortality. Total mortality numbered 
5 (5.3%), one case in group A and four cases in group B. The cause 
of mortality was acute cardiopulmonary failure due to uncontrolled 
infection and complications.
Discussion
The treatment outcomes of patients with CHD have dramatically 
improved over the past several decades, with an increase in long-
term survival. This has resulted in an increased number of CHD pa-
tients diagnosed with IE.3) CHD has been reported as 9-28%,3)5) and 
17-26%11)12) of the causes of IE in Korea, suggesting a causative role 
of CHD in IE. In our study, 28.6% of patients diagnosed with IE had 
underlying CHD. The high prevalence of IE at our institute com-
pared to the other domestic institutes, in part, results from the in-
creased survival rate of CHD patients due to improved treatment 
methods, as well as the increased number of patients undergoing 
long-term follow-up at our institute, which runs a CHD center. 
Patients with CHD have a possibility of IE in their lifetime, but the 
occurrence rate differs according to the type of CHD. Uncorrected 
VSD patients showed a high risk for IE13-15) and, in our study, VSD 
was the most commonly observed underlying CHD in both groups A 
and B. However, the larger percentage of patients with a cyanotic 
complex cardiac anomaly were observed in group B. This was likely 
due to an improvement in the early detection of CHD and improved 
surgical techniques, such as use of prosthetic materials, with pa-
tients consequently undergoing those procedures earlier in life. 
Consequently, there was a decreased risk of IE due to unrepaired 
simple CHD and the improved long-term survival rate of patients 
with a complex cardiac anomaly. The differences between the two 
groups are probably due to the improved treatment modality and 
improved treatment outcomes.13)16)
In the year 2000, the year that divides the two study groups, Ko-
rea implemented a nationwide systemic change, separating the 
prescribing and dispensing of pharmaceuticals, and regulating the 
use of antibiotics under national guidelines. 
Previous studies have shown that 2.5-31% of IE patients did not 
have an identified microorganism in the blood culture.17) This is less 
than the 37.6% found in our study, and although we found no 
statistically significant differences between group A (44.1%) and 
group B (26.5%), we noticed a decreasing trend in group B. Consid-
ering that the most common cause of non-identifiable microorgan-
ism in IE is antibiotic use prior to acquiring a blood sample, the 
changed health system regulating the use of antibiotics may be as-
sociated with this change.
The prevalence of IE due to Staphylococcus has previously been 
reported as having increased in patients who underwent previous 
cardiac surgery, compared to IE due to viridians streptococci.18) In 
our study, the most common pathogen of IE was viridians Strepto-
cocci in both groups, and IE due to Staphylococcus was compara-
bly low. However, the prevalence rate of Staphylococcus infection 
in group B indicated an increase. IE due to fungus was reported to 
be dominant in patients who had previously undergone open heart 
surgery, were exposed to the long-term use of broad spectrum an-
tibiotics, and had had intravenous catheter insertion.19) IE due to 
fungus has previously been shown to be increasing,20) but our study 
showed a decreasing tendency.
The most common complication reported in the literature was 
heart failure, at 15-65%,21) which appears to be in line with the find-
ings of 31.2% in our study. However, the number of patients who 
underwent a surgical correction of IE due to uncontrolled infection 
after the intravenous injection of antibiotics increased in group B 
to 29.4% (compared to 5.1% in group A), and this was higher than 
the 14%22) reported previously. Given that the indication for surgery 
is “uncontrolled infection”, surgical correction of IE has also in-
creased in recent years. Mortality has been reported as between 
7% and 8%,15)23)24) but we found an overall lower percentage (5.3%), 
although the mortality rate increased to 11.7% in group B. These 
results probably reflect the increased number of patients undergo-
ing palliative treatment or prosthetic material surgery. Consequently, 
there was an increase in the number of IE high-risk patients16) and 
likely an increase in uncontrolled infection, leading to a higher rate 
of surgical correction among IE patients.
This study has a number of limitations. Our study was a nonran-
domized controlled trial conducted retrospectively by reviewing 
medical records, which may not properly reflect the medical tech-
nology status, environmental changes, and societal changes and 
their ramifications. Furthermore, we lacked data on antibiotic pro-
phylaxis before high-risk procedures, such as dental procedures or 
gastro-intestinal tract manipulation. However, this study is mean-
ingful in that a single protocol was able to be evaluated over a long 
period of time at a single institute. 
In conclusion, IE and CHD present a close correlation, and the 
profile of IE patients can change according to the tendency of an 
early correction for CHD and the development of diagnostic modal-
ities. These changes were likely due to an increase in the long-term 
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survival rate of patients with complex CHD and an improvement in 
surgical techniques, such as the use of prosthetic materials. Ongo-
ing reassessment and the systematic management of these pa-
tients is crucial in the prevention and treatment of IE, especially 
for patients with complex CHD.
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